JPH0144182B2 - - Google Patents

Info

Publication number
JPH0144182B2
JPH0144182B2 JP660982A JP660982A JPH0144182B2 JP H0144182 B2 JPH0144182 B2 JP H0144182B2 JP 660982 A JP660982 A JP 660982A JP 660982 A JP660982 A JP 660982A JP H0144182 B2 JPH0144182 B2 JP H0144182B2
Authority
JP
Japan
Prior art keywords
iodopropyn
pyrrole
nitropyrrole
chloro
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP660982A
Other languages
Japanese (ja)
Other versions
JPS58124765A (en
Inventor
Masao Koyama
Takashi Tsuruoka
Keinosuke Myauchi
Kuniomi Matsumoto
Shigeharu Inoe
Taro Niida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP660982A priority Critical patent/JPS58124765A/en
Priority to DE8282109236T priority patent/DE3268983D1/en
Priority to EP19820109236 priority patent/EP0080051B1/en
Publication of JPS58124765A publication Critical patent/JPS58124765A/en
Publication of JPH0144182B2 publication Critical patent/JPH0144182B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は、一般式() 〔式中、R1、R2は水素原子、塩素原子、ニトロ
基又はメトキシカルボニル基を示す、但し共に水
素原子を示す場合を除く、R3は水素原子、ニト
ロ基又は3−クロロ−2−ニトロフエニル基を示
す〕 で表される新規ピロール誘導体及びそれを有効
成分とする抗かび剤に関するものである。 本発明者等は先に微生物の醗酵液中より新抗生
物質ピロロマイシンA(SF−2080A)を得、当該
物質、製法及びそれを有効成分とする抗かび剤に
ついて特許出願をした(特開昭56−90099号公報、
特開昭57−67557号公報)。ついで、本発明者等は
ピロロマイシンAにおいて抗かび活性増強の目的
で化学反応による構造修飾を行つたところ、当該
物質のピロール環窒素上に、ヨードプロパギル基
を導入すると抗かび活性が著しく増強されること
を見出した。 更に本発明者等はヨードプロパルギル基の導入
による抗かび活性の増強がピロロマイシンA以外
の他のピロール化合物において顕著であることを
見出して本発明を完成させるに至つた。 本発明の前記式()で表されるピロール誘導
体は文献未載の新規化合物である。 本発明により提供されるピロール誘導体として
は例えば次のものが挙げられる。 (1) 1−(1′−ヨードプロピン−3′−イル)2−,
3−ジクロロ−4−ニトロピロール (2) 1−(1′−ヨードプロピン−3′−イル)−2−
クロロ−4−ニトロピロール (3) 1−(1′−ヨードプロピン−3′−イル)−3−
ニトロピロール (4) 1−(1′−ヨードプロピン−3′−イル)−3−
クロロ−4−(3″−クロロ−2″−ニトロフエニ
ル)ピロール (5) 1−(1′−ヨードプロピン−3′−イル)−2−
メトキシカルボニルピロール (6) 1−(1′−ヨードプロピン−3′−イル)−2−
ニトロピロール 本発明によるピロール誘導体()は下記の反
応式に示すように、ピロール化合物()及びヨ
ードプロピン誘導体()〔反応式中、R1、R2
R3は前記と同一意義を有す、Xはハロゲン原子
もしくはスルホン酸エステルとして活性化された
水酸基を示す〕を不活性溶媒中、塩基の存在下で
反応させて製造される。 本発明化合物の製造に際し使用される原料物質
のうちヨードプロピン誘導体()は公知の化合
物であり、例えばヨードプロパルギルアルコール
に塩化チオニルもしくは臭化チオニルのごときハ
ロゲン化剤を反応させてヨードプロパルギルハラ
イドとするか、あるいはトルエンスルホニルクロ
リド、ベンゼンスルホニルクロリドもしくはメタ
ンスルホニルクロリドのようなスルホン酸ハライ
ドを反応させてヨードプロパルギルアルコールス
ルホネートとして得られるものである。 本発明の化合物の製造に使用される他方の原料
物質である前記式()で表されるピロール化合
物のうち、例えば2,3−ジクロロ−4−ニトロ
ピロール(ピロロマイシンA)及び3−クロロ−
4−(3′−クロロ−2′−ニトロフエニル)ピロー
ル(ピロールニトリン)は微生物の醗酵生産物と
して良く知られたものであり、3−ニトロピロー
ルはテトラヘドロン(Tetrahedron)誌22巻57頁
(1966年)記載の方法により合成され、その他の
原料物質は以上述べた物質の製造方法を応用する
ことをにより当該技術熟練者が合成することがで
きる。 本発明によれば式()で表されるピロール誘
導体は、上記に従つて得られた出発物質である式
()で表されるピロール化合物を不活性溶媒に
溶解し、式()で表されるヨードプロピル誘導
体及び塩基を添加して式()で表されるピロー
ル化合物のピロール環窒素原子上にヨードプロパ
ルギル基を導入するN−アルキル化反応により製
造される。本反応に用いる不活性溶媒の例として
はベンゼン、ジオキサン、ジクロロメタン、N,
N−ジメチルホルムアミドであり、また反応に用
いられる塩基の例としては、水酸化アルカリ、炭
酸アルカリ等の無機塩基の他、有機塩基例えばト
リエチルアミン等が使用される。反応は水酸化ア
ルカリの使用にあたつては室温で速やかに進行す
るが、副反応防止の目的で冷却下、好ましくは0
〜5℃で行わせるか、あるいは有機塩基を使用し
40〜60℃に加温して行うこともできる。反応混合
物中よりの目的物である式()で表されるピロ
ール誘導体の単離は、不溶性溶媒例えば水等の添
加による晶出法又は有機溶媒、例えばベンゼン、
酢酸エチル等を用いた抽出法もしくはそれらに必
要に応じて良く知られた精製方法、例えばシリカ
ゲルを用いたクロマトグラフイーあるいは有機溶
媒による再結晶法を併用して行われる。 本発明における新規なピロール誘導体()の
製造例を以下に示す。 例 1 1−(1′−ヨードプロピン−3′−イル)−2,3
−ジクロロ−4−ニトロピロール 2,3−ジクロロ−4−ニトロピロール(ピロ
ロマイシンA)181mg(1ミリモル)を乾燥ジメ
チルホルムアミド10mlに溶解し、ヨードプロパル
ギルアルコールのp−トルエンスルホン酸エステ
ル340mg(1ミリモル)及び粉末化した水酸化ナ
トリウム50mgを加えて、0〜5℃で1時間かきま
ぜた。反応液に水30ml及びベンゼン50mlを加え抽
出し、ベンゼン層を分液後2回水洗した。ベンゼ
ン溶液を乾燥後、減圧濃縮して得た残留物に少量
のメタノールを加え、析出した1−(1′−ヨード
プロピン−3′−イル)−2・3−ジクロロ−4−
ニトロピロール結晶を濾取した。収量198mg(58
%)、融点128〜131℃、元素分析値C:24.48%
H:0.83%、N:7.95%、Cl及びI:57.78%、
C7H3N2O2Cl2Iとしての計算値C:24.35%、H:
0.88%、N:8.12%、Cl:20.56%:I:36.79%。 例 2 1−(1′−ヨードプロピン−3′−イル)−3−ニ
トロピロール 3−ニトロピロール224mg(2ミリモル)を乾
燥ジメチルホルムアミド5mlに溶解し、ヨードプ
ロパルギルアルコールのp−トルエンスルホン酸
エステル0.67g(2ミリモル)及び水酸化ナトリ
ウム粉末100mgを加えて10〜5℃で1時間かきま
ぜた。反応液に酢酸エチル及び水各50mlを加え、
抽出し、酢酸エチル層を分液後、水洗、乾燥し
た。酢酸エチル溶液を減圧下に濃縮して得た残留
物にメタノール1.5mlを加えると、1−(1′−ヨー
ドプロピン−3′−イル)−3−ニトロピロール結
晶が析出したので濾取した。収量236mg(43%)、
融点138〜140℃、元素分析値C:31.31%、H:
1.89%、N:10.06%、I:45.34%、 C3H5N2O2Iとしての計算値C:30.47%、H:
1.83%、N:10.14%、I:45.97% 例 3 1−(1′−ヨードプロピン−3′−イル)−3−ク
ロロ−4−(3′−クロロ−2′ニトロフエニル)
ピロール 3−クロロ−4−(3′−クロロ−2′−ニトロフ
エニル)ピロール(ピロールニトリン)130mgを
乾燥ジメチルホルムアミド5mlに溶解し、0〜5
℃に冷却した。ヨードプロパルギルアルコールの
p−トルエンスルホン酸エステル168mg及び水酸
化ナトリウム粉末24mgを加え、1時間かきまぜた
後、反応液を氷水10ml中に注いだ。反応液をベン
ゼン−酢酸エチル混合物溶媒20mlcm2抽出し、有機
溶媒層を水洗、乾燥後、減圧下に濃縮すると暗褐
色の固体が残留した。メタノール1mlを加え析出
した1−(1″−ヨードプロピン−3″−イル)−3−
クロロ−4−(3′−クロロ−2−ニトロフエニル)
ピロール結晶を濾取した。収量97mg(46%)、融
点126〜128℃、元素分析値C:38.34%、H:
1.76%、N:6.83%、Cl及びI:45.73%、
C13H7N2O2Cl2I2としての計算値C:37.09%、
H:1.08%、N:6.65%、Cl:16.84%、I:
30.14%。 例 4 1−(1′−ヨードプロピン−3′−イル)−2−メ
トキシカルボニルピロール2−カルボメトキシ
ピロール125mg(1ミリモル)を乾燥ジメチル
ホルムアミド5mlに溶解し、ヨードプロパルギ
ルアルコールのp−トルエンスルホン酸エステ
ル340mg(1ミリモル)を加え、激しくかきま
ぜながら水酸化ナトリウム粉末46mgを加えた。
室温で20分間反応させたのち、反応液と酢酸エ
チル及び水に分配した。酢酸エチル層を分液
し、飽和食塩水で2回洗い乾燥した。酢酸エチ
ル溶液を濃縮したのち残留した暗色の油状物を
シリカゲルTLC板上で精製し、結晶性の1−
(1′−ヨードプロピン−3′−イル)−2−メトキ
シカルボニルピロールを得た。収量149mg(51
%)。元素分析値C:38.01%、H:2.99%、
N:4.67%、I:42.90%、C9H8NO2Iとしての
計算値C:37.39%、H:2.79%、N:4.85%、
I:42.90%、IRスペクトル2180Cm-1(−C≡C
−)、1685Cm-1(−COO−)。 例 5 1−(1′−ヨードプロピン−3′−イル)−2−ニ
トロピロール 2−ニトロピロール1.12g(10ミリモル)をジ
メチルホルムアミド20mlに溶解し、水酸化ナトリ
ウム粉末0.45g(11ミリモル)を加え、良くかき
まぜて溶解させた。この溶液を氷冷しヨードプロ
パルギルアルコール・p−トルエンスルホン酸エ
ステル3.36g(10ミリモル)を加え、氷冷下に1
時間、更に室温で15時間反応させた。反応液に氷
水30mlを加え、析出した1−(1′−ヨードプロピ
ン−3′−イル)−2−ニトロピロール結晶を濾過
し水洗、乾燥した。収量2.28g(82%) 粗結晶をメタノールから再結晶して融点102〜
104℃の精製結晶を得た。元素分析値C:30.40
%、H:1.81%、N:9.99%、I:44.52% C7H5N2O2Iとしての計算値C:30.46%、H:
1.83%、N:10.14%、I:45.97% 本発明の前記式()で表される新規なピロー
ル誘導体は低毒性の化合物であり、抗菌、抗かび
剤として有用である。特に本発明の化合物は広範
囲のかび類に対し発育阻止作用を示すところか
ら、医療を始めとし、農業及び工業の各分野にお
いて、細菌及びかび類の生育に起因する好ましく
ない諸条件の改善に役立つものである。すなわ
ち、医療用には例えばキヤンデイダ属、アスペル
ギルス属、トリコフイトン属、クリプトコツカス
属を始めとするかび類に起因する外部疾患の治療
薬として、液剤及び軟膏の有効成分として0.1〜
5%、好ましくは0.5〜2%の範囲で配合し、患
部に塗布して治療の目的を達することができる。
更にその他、医療用として病原菌、かび類の生育
を予防し、無菌環境を保全する目的で、機械器具
の消毒剤、その他の有効成分として含有させるこ
とができる。 更に本発明の式()で表されるピロール誘導
体は農業及び工業用の分野においても有用性を示
すものである。特にこれら分野では、例えば種
子、苗、木材及び木工品、紙工芸品、皮革、接着
剤、塗料、合成樹脂等の農業、工業用製品及びそ
の製造環境、例えば用水における腐販菌、かびの
発生は商品の価値にとつて重大な損失を招くもの
である。本発明のピロール誘導体は、農業及び工
業の分野における有害な細菌、かび類に対して発
育阻止作用を示すところから分野における製品の
品質保持及び環境の保全の目的に供することがで
きる。 農業、工業分野における本発明のピロール誘導
体の使用形態としては通常用いられる担体上に保
持した製剤、即ち油溶剤、乳剤、ペースト剤、粉
剤、水和剤、エアゾール剤、防かび性塗料等があ
げられる。用いられる担体としては、例えばクレ
ー、タルク、ベントナイト、カオリン、無水硅
酸、炭酸カルシウム等の無機性固体担体、チロシ
ン、リグロイン、キシレン、DMF、DMSO等の
有機溶媒系担体、ジメチルエーテル、フロンガス
等のガス担体があげられ、製剤効果をより高める
ための補助剤としては、イオン性、非イオン性の
界面活性剤、並びに酢酸ビニル、メチルセルロー
ス等の高分子化合物等があり、サイアベンダゾー
ルを始めとする他の防腐、防かび剤やクロルデン
等の殺虫剤との併用も可能である。 実際の使用に際しての本発明のピロール誘導体
の含量は製剤形態に従つて、種々に考えられる
が、一般には0.01〜95重量%、好ましくは0.2〜
10重量%の範囲が適当である。農業及び工業用抗
菌、抗かび剤としての製剤例を以下にあげる。 製剤例 1 水和剤 1−(1′−ヨードプロピン−3′−イル)−2,3
−ジクロロ−4−ニトロピロール40重量部とポリ
オキシエチレンアルキルアリ−ルエ−テル5重量
部、リグニンスルホン酸3重量部及び硅藻±52重
量部を均一に粉砕混合すれば有効成分40%を含む
水和剤を得る。 製剤例 2 粒剤 1−(1′−ヨードプロピン−3′−イル)−2,3
−ジクロロ−4−ニトロピロール12重量部、リグ
ニンスルホン酸カルシウム1重量部、ベントナイ
ト30重量部及びクレー57重量部を均一に粉砕混合
し、次に適当量の水を加えて練合した後に造粒し
て乾燥すれば有効成分12%を含む粒剤を得る。 製剤例 3 乳剤 1−(1′−ヨードプロピン−3′−イル)−3−ニ
トロピロール20重量部、ジメチルホルムアミド30
重量部、キシレン35重量部、ポリオキシエチレン
アルキルアリ−ルエ−テル15重量部を均一に混合
すれば有効成分20%を含む乳剤を得る。 製剤例 4 粉剤 1−(1′−ヨードプロピン−3′−イル)−2,3
−ジクロロ−4−ニトロピロール3重量部、無水
硅酸微粉末0.5重量部、ステアリン酸カルシウム
0.5重量部、クレー50重量部及びタルク46重量部
を均一に粉砕、混合すれば有効成分3%を含む粉
剤を得る。 次に、本発明のピロール誘導体の有用性を具体
的に示す例として、1−(1′−ヨードプロピン−
3′−イル)−2,3−ジクロロ−4−ニトロピロ
ール〔化合物()〕、1−(1′−ヨードプロピン
−3′−イル)−3−ニトロピロール〔化合物(2)〕
の急性毒性(表1)、上記化合物(1)及び(2)と1−
(1′−ヨードプロピン−3″−イル)−3−クロロ−
4−(3′−クロロ−2′−ニトロフエニル)ピロー
ル〔化合物(3)〕、1−(1′−ヨードプロピン−3′−
イル)−2−メトキシカルボニルピロール〔化合
物(4)〕の抗菌、抗かび活性(表2.3及び4)及び
モルモツトにおける水虫感染症の治療実験を詳細
に記す。
The present invention is based on the general formula () [In the formula, R 1 and R 2 represent a hydrogen atom, a chlorine atom, a nitro group, or a methoxycarbonyl group, except when both represent a hydrogen atom, and R 3 represents a hydrogen atom, a nitro group, or a 3-chloro-2- The present invention relates to a novel pyrrole derivative represented by the following formula (indicating a nitrophenyl group) and an antifungal agent containing the same as an active ingredient. The present inventors previously obtained a new antibiotic, pyrrolomycin A (SF-2080A), from a fermentation solution of microorganisms, and filed a patent application for the substance, its production method, and an antifungal agent containing it as an active ingredient (Japanese Patent Application Laid-Open No. Publication No. 56-90099,
(Japanese Patent Application Laid-open No. 57-67557). Next, the present inventors modified the structure of pyrrolomycin A through a chemical reaction for the purpose of enhancing its antifungal activity, and found that the antifungal activity was significantly enhanced when an iodopropargyl group was introduced onto the nitrogen of the pyrrole ring of the substance. I found out that it can be done. Furthermore, the present inventors have found that the antifungal activity is significantly enhanced in pyrrole compounds other than pyrrolomycin A by introducing an iodopropargyl group, and have completed the present invention. The pyrrole derivative represented by the above formula () of the present invention is a novel compound that has not been described in any literature. Examples of the pyrrole derivatives provided by the present invention include the following. (1) 1-(1'-iodopropyn-3'-yl)2-,
3-dichloro-4-nitropyrrole (2) 1-(1'-iodopropyn-3'-yl)-2-
Chloro-4-nitropyrrole (3) 1-(1'-iodopropyn-3'-yl)-3-
Nitropyrrole (4) 1-(1'-iodopropyn-3'-yl)-3-
Chloro-4-(3″-chloro-2″-nitrophenyl)pyrrole (5) 1-(1′-iodopropyn-3′-yl)-2-
Methoxycarbonylpyrrole (6) 1-(1'-iodopropyn-3'-yl)-2-
Nitropyrrole The pyrrole derivative () according to the present invention is a pyrrole compound () and an iodopropylene derivative () [in the reaction formula, R 1 , R 2 ,
R 3 has the same meaning as above, X represents a halogen atom or a hydroxyl group activated as a sulfonic acid ester] in an inert solvent in the presence of a base. Among the raw materials used in the production of the compounds of the present invention, iodopropyne derivatives () are known compounds.For example, iodopropargyl halide can be obtained by reacting iodopropargyl alcohol with a halogenating agent such as thionyl chloride or thionyl bromide. Alternatively, it can be obtained as iodopropargyl alcohol sulfonate by reacting a sulfonic acid halide such as toluenesulfonyl chloride, benzenesulfonyl chloride or methanesulfonyl chloride. Among the pyrrole compounds represented by the above formula (), which are the other raw materials used in the production of the compound of the present invention, examples include 2,3-dichloro-4-nitropyrrole (pyrrolomycin A) and 3-chloro-
4-(3'-Chloro-2'-nitrophenyl)pyrrole (pyrrolnitrine) is a well-known microbial fermentation product, and 3-nitropyrrole is reported in Tetrahedron, Vol. 22, p. 57 ( (1966), and other raw materials can be synthesized by those skilled in the art by applying the above-mentioned methods for producing the substances. According to the present invention, the pyrrole derivative represented by the formula () can be obtained by dissolving the pyrrole compound represented by the formula (), which is the starting material obtained according to the above method, in an inert solvent. It is produced by an N-alkylation reaction in which an iodopropyl derivative and a base are added to introduce an iodopropargyl group onto the nitrogen atom of the pyrrole ring of a pyrrole compound represented by formula (). Examples of inert solvents used in this reaction include benzene, dioxane, dichloromethane, N,
Examples of bases used in the reaction include inorganic bases such as alkali hydroxide and alkali carbonate, as well as organic bases such as triethylamine. When using alkali hydroxide, the reaction proceeds rapidly at room temperature, but in order to prevent side reactions, the reaction is preferably carried out under cooling, preferably at zero temperature.
Perform at ~5°C or use an organic base.
It can also be carried out by heating to 40 to 60°C. The target pyrrole derivative represented by formula () can be isolated from the reaction mixture by a crystallization method by adding an insoluble solvent such as water or an organic solvent such as benzene,
Extraction using ethyl acetate or the like or, if necessary, a well-known purification method such as chromatography using silica gel or recrystallization using an organic solvent may be used in combination. A production example of the novel pyrrole derivative () according to the present invention is shown below. Example 1 1-(1'-iodopropyn-3'-yl)-2,3
-Dichloro-4-nitropyrrole 181 mg (1 mmol) of 2,3-dichloro-4-nitropyrrole (pyrrolomycin A) was dissolved in 10 ml of dry dimethylformamide, and 340 mg (1 mmol) of p-toluenesulfonic acid ester of iodopropargyl alcohol was dissolved. ) and 50 mg of powdered sodium hydroxide were added and stirred at 0 to 5°C for 1 hour. 30 ml of water and 50 ml of benzene were added to the reaction solution for extraction, and the benzene layer was separated and washed twice with water. After drying the benzene solution, a small amount of methanol was added to the residue obtained by concentrating the benzene solution under reduced pressure, and the precipitated 1-(1'-iodopropyn-3'-yl)-2,3-dichloro-4-
Nitropyrrole crystals were collected by filtration. Yield 198 mg (58
%), melting point 128-131℃, elemental analysis value C: 24.48%
H: 0.83%, N: 7.95%, Cl and I: 57.78%,
Calculated value as C 7 H 3 N 2 O 2 Cl 2 I C: 24.35%, H:
0.88%, N: 8.12%, Cl: 20.56%: I: 36.79%. Example 2 1-(1'-iodopropyn-3'-yl)-3-nitropyrrole 224 mg (2 mmol) of 3-nitropyrrole was dissolved in 5 ml of dry dimethylformamide and 0.67 g of p-toluenesulfonic acid ester of iodopropargyl alcohol was prepared. (2 mmol) and 100 mg of sodium hydroxide powder were added and stirred at 10-5°C for 1 hour. Add 50ml each of ethyl acetate and water to the reaction solution,
After extraction, the ethyl acetate layer was separated, washed with water, and dried. When 1.5 ml of methanol was added to the residue obtained by concentrating the ethyl acetate solution under reduced pressure, 1-(1'-iodopropyn-3'-yl)-3-nitropyrrole crystals precipitated and were collected by filtration. Yield 236mg (43%),
Melting point 138-140℃, elemental analysis value C: 31.31%, H:
1.89%, N: 10.06%, I: 45.34%, Calculated value as C 3 H 5 N 2 O 2 I C: 30.47%, H:
1.83%, N: 10.14%, I: 45.97% Example 3 1-(1'-iodopropyn-3'-yl)-3-chloro-4-(3'-chloro-2'nitrophenyl)
Pyrrole Dissolve 130 mg of 3-chloro-4-(3'-chloro-2'-nitrophenyl)pyrrole (pyrrolnitrine) in 5 ml of dry dimethylformamide,
Cooled to ℃. 168 mg of p-toluenesulfonic acid ester of iodopropargyl alcohol and 24 mg of sodium hydroxide powder were added, and after stirring for 1 hour, the reaction solution was poured into 10 ml of ice water. The reaction solution was extracted with a benzene-ethyl acetate mixture (20 ml cm 2 ) , and the organic solvent layer was washed with water, dried, and concentrated under reduced pressure to leave a dark brown solid. Add 1 ml of methanol to precipitate 1-(1″-iodopropyn-3″-yl)-3-
Chloro-4-(3'-chloro-2-nitrophenyl)
Pyrrole crystals were collected by filtration. Yield 97 mg (46%), melting point 126-128°C, elemental analysis C: 38.34%, H:
1.76%, N: 6.83%, Cl and I: 45.73%,
Calculated value C as C 13 H 7 N 2 O 2 Cl 2 I 2 : 37.09%,
H: 1.08%, N: 6.65%, Cl: 16.84%, I:
30.14%. Example 4 1-(1'-iodopropyn-3'-yl)-2-methoxycarbonylpyrrole 125 mg (1 mmol) of 2-carbomethoxypyrrole was dissolved in 5 ml of dry dimethylformamide to prepare p-toluenesulfonic acid ester of iodopropargyl alcohol. 340 mg (1 mmol) was added and 46 mg of sodium hydroxide powder was added with vigorous stirring.
After reacting at room temperature for 20 minutes, the reaction solution was partitioned between ethyl acetate and water. The ethyl acetate layer was separated, washed twice with saturated brine, and dried. After concentrating the ethyl acetate solution, the dark oil that remained was purified on a silica gel TLC plate to obtain crystalline 1-
(1'-iodopropyn-3'-yl)-2-methoxycarbonylpyrrole was obtained. Yield 149 mg (51
%). Elemental analysis value C: 38.01%, H: 2.99%,
N: 4.67%, I: 42.90%, Calculated value as C 9 H 8 NO 2 I C: 37.39%, H: 2.79%, N: 4.85%,
I: 42.90%, IR spectrum 2180 Cm-1 (-C≡C
−), 1685 Cm-1 (−COO−). Example 5 1-(1'-iodopropyn-3'-yl)-2-nitropyrrole 1.12 g (10 mmol) of 2-nitropyrrole was dissolved in 20 ml of dimethylformamide, and 0.45 g (11 mmol) of sodium hydroxide powder was added. , stir well to dissolve. Cool this solution on ice, add 3.36 g (10 mmol) of iodopropargyl alcohol/p-toluenesulfonic acid ester, and cool on ice for 1 hour.
The reaction was further continued for 15 hours at room temperature. 30 ml of ice water was added to the reaction solution, and the precipitated 1-(1'-iodopropyn-3'-yl)-2-nitropyrrole crystals were filtered, washed with water, and dried. Yield: 2.28g (82%) Crude crystals were recrystallized from methanol, melting point: 102~
Purified crystals at 104°C were obtained. Elemental analysis value C: 30.40
%, H: 1.81%, N: 9.99%, I: 44.52% Calculated value as C 7 H 5 N 2 O 2 I C: 30.46%, H:
1.83%, N: 10.14%, I: 45.97% The novel pyrrole derivative of the present invention represented by the above formula () is a low toxicity compound and is useful as an antibacterial and antifungal agent. In particular, the compound of the present invention exhibits a growth inhibiting effect on a wide range of fungi, and is therefore useful in improving unfavorable conditions caused by the growth of bacteria and fungi in various fields of medicine, agriculture, and industry. It is something. That is, for medical use, for example, as a therapeutic agent for external diseases caused by fungi such as Candida, Aspergillus, Trichophyton, and Cryptococcus, the active ingredient in liquid preparations and ointments ranges from 0.1 to
It can be blended in an amount of 5%, preferably in the range of 0.5 to 2%, and applied to the affected area to achieve the therapeutic purpose.
Furthermore, for medical purposes, it can be included as a disinfectant for machinery and equipment and other active ingredients for the purpose of preventing the growth of pathogenic bacteria and molds and maintaining a sterile environment. Furthermore, the pyrrole derivative represented by formula () of the present invention also shows usefulness in the agricultural and industrial fields. In particular, in these fields, for example, agricultural and industrial products such as seeds, seedlings, wood and woodwork, paper crafts, leather, adhesives, paints, and synthetic resins, and their manufacturing environments, such as the occurrence of spoilage bacteria and mold in drinking water. causes a significant loss in the value of the product. Since the pyrrole derivative of the present invention exhibits a growth inhibiting effect on harmful bacteria and fungi in the agricultural and industrial fields, it can be used for the purpose of maintaining the quality of products in the field and preserving the environment. In the agricultural and industrial fields, the pyrrole derivative of the present invention can be used in formulations supported on commonly used carriers, such as oil solvents, emulsions, pastes, powders, wettable powders, aerosols, and antifungal coatings. It will be done. Examples of carriers used include inorganic solid carriers such as clay, talc, bentonite, kaolin, silicic anhydride, and calcium carbonate, organic solvent carriers such as tyrosine, ligroin, xylene, DMF, and DMSO, and gases such as dimethyl ether and chlorofluorocarbon gas. Examples include carriers, and adjuvants to further enhance formulation effects include ionic and nonionic surfactants, as well as polymeric compounds such as vinyl acetate and methylcellulose. It is also possible to use it in combination with preservatives, fungicides, and insecticides such as chlordane. The content of the pyrrole derivative of the present invention in actual use may vary depending on the formulation, but it is generally 0.01 to 95% by weight, preferably 0.2 to 95% by weight.
A range of 10% by weight is suitable. Examples of formulations as agricultural and industrial antibacterial and antifungal agents are listed below. Formulation example 1 Wettable powder 1-(1'-iodopropyn-3'-yl)-2,3
- If 40 parts by weight of dichloro-4-nitropyrrole, 5 parts by weight of polyoxyethylene alkyl aryl ether, 3 parts by weight of lignin sulfonic acid, and ±52 parts by weight of diatom are uniformly ground and mixed, 40% of the active ingredient will be contained. Obtain a hydrating powder. Formulation example 2 Granules 1-(1'-iodopropyn-3'-yl)-2,3
- 12 parts by weight of dichloro-4-nitropyrrole, 1 part by weight of calcium lignosulfonate, 30 parts by weight of bentonite and 57 parts by weight of clay are uniformly ground and mixed, then an appropriate amount of water is added and kneaded, followed by granulation. When dried, granules containing 12% of the active ingredient are obtained. Formulation Example 3 Emulsion 20 parts by weight of 1-(1'-iodopropyn-3'-yl)-3-nitropyrrole, 30 parts by weight of dimethylformamide
By uniformly mixing 35 parts by weight of xylene and 15 parts by weight of polyoxyethylene alkylaryl ether, an emulsion containing 20% of the active ingredient is obtained. Formulation example 4 Powder 1-(1'-iodopropyn-3'-yl)-2,3
-3 parts by weight of dichloro-4-nitropyrrole, 0.5 parts by weight of silicic anhydride fine powder, calcium stearate
By uniformly pulverizing and mixing 0.5 parts by weight, 50 parts by weight of clay, and 46 parts by weight of talc, a powder containing 3% of the active ingredient is obtained. Next, as a concrete example showing the usefulness of the pyrrole derivative of the present invention, 1-(1'-iodopropyne-
3'-yl)-2,3-dichloro-4-nitropyrrole [Compound ()], 1-(1'-iodopropyn-3'-yl)-3-nitropyrrole [Compound (2)]
acute toxicity (Table 1), the above compounds (1) and (2) and 1-
(1′-iodopropyn-3″-yl)-3-chloro-
4-(3'-chloro-2'-nitrophenyl)pyrrole [compound (3)], 1-(1'-iodopropyne-3'-
The antibacterial and antifungal activities (Tables 2.3 and 4) of 2-methoxycarbonylpyrrole (compound (4)) and the experimental treatment of athlete's foot infection in guinea pigs are described in detail.

【表】 わたり毒性的影響を認めず。
[Table] No toxic effects observed.

【表】【table】

【表】【table】

【表】【table】

【表】 治療実験例 白色ハートリイ(Hartly)系モルモツト(一
群3匹)の背部皮膚4ケ所(左右各2,4×6
cm)を抜糸後、トリコフイトン・メンタグロフイ
テス浮遊液(液体サブロー培地、生菌数2×
107/ml)を各部位0.5mlずつ刷毛により塗布す
る。菌接種の2日後より病巣皮膚左右各1ケ所に
ついて、試験化合物の製剤(表5)を0.25mlずつ
1日1回、8日間連続して塗布した。
[Table] Treatment experiment example: 4 dorsal skin areas (2, 4 x 6 on each left and right) of white Hartly guinea pigs (3 animals per group)
After removing the sutures (cm), remove the Trichophyton mentagrophytes suspension (liquid Sabouraud medium, 2x viable bacteria).
Apply 0.5 ml of 10 7 /ml to each area with a brush. Two days after inoculation, 0.25 ml of the test compound formulation (Table 5) was applied once a day for 8 consecutive days to one site on each side of the skin of the lesion.

【表】 同様の操作をピロールニトリン〔3−クロロ−
4−(2′−ニトロ−3′−クロロフエニル)ピロー
ル〕1%製剤及びクロトリマゾール〔1−(0−
クロロ−α,αジフエニルベンジル)イミダゾー
ル〕1%製剤についても行い無処置群と併せ、比
較対照とした。肉眼所見による効果判定では、患
部皮膚の肥厚、潮紅、鱗屑のいずれにおいても本
発明の化合物は良い治療成積を収めた(表6)。
[Table] Similar operations were performed on pyrrolenitrine [3-chloro-
4-(2'-nitro-3'-chlorophenyl)pyrrole] 1% preparation and clotrimazole [1-(0-
A 1% formulation of chloro-α,αdiphenylbenzyl)imidazole was also tested and used as a control, along with a non-treated group. When efficacy was evaluated based on macroscopic findings, the compound of the present invention achieved good therapeutic results in all cases of thickening, flushing, and scaling of the affected skin (Table 6).

【表】【table】

Claims (1)

【特許請求の範囲】 1 式 〔式中、R1、R2は水素原子、塩素原子、ニトロ
基又はメトキシカルボニル基を示す、但し共に水
素原子を示す場合を除く、R3は水素原子、ニト
ロ基又は3−クロロ−2−ニトロフエニル基を示
す〕 で表されるピロール誘導体。 2 式 〔式中、R1、R2は水素原子、塩素原子、ニトロ
基又はメトキシカルボニル基を示す、但し共に水
素原子を示す場合を除く、R3は水素原子、ニト
ロ基又は3−クロロ−2−ニトロフエニル基を示
す〕 で表されるピロール誘導体を有効成分とする抗か
び剤。
[Claims] 1 formula [In the formula, R 1 and R 2 represent a hydrogen atom, a chlorine atom, a nitro group, or a methoxycarbonyl group, except when both represent a hydrogen atom, and R 3 represents a hydrogen atom, a nitro group, or a 3-chloro-2- A pyrrole derivative represented by [representing a nitrophenyl group]. 2 formulas [In the formula, R 1 and R 2 represent a hydrogen atom, a chlorine atom, a nitro group, or a methoxycarbonyl group, except when both represent a hydrogen atom, and R 3 represents a hydrogen atom, a nitro group, or a 3-chloro-2- An antifungal agent whose active ingredient is a pyrrole derivative represented by the following formula, which represents a nitrophenyl group.
JP660982A 1981-10-07 1982-01-19 Pyrrole derivative, its preparation, and antifungal containing the same as active ingredient Granted JPS58124765A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP660982A JPS58124765A (en) 1982-01-19 1982-01-19 Pyrrole derivative, its preparation, and antifungal containing the same as active ingredient
DE8282109236T DE3268983D1 (en) 1981-10-07 1982-10-06 Heterocyclic compounds and antibacterial and antifungal compositions containing the same as active ingredients
EP19820109236 EP0080051B1 (en) 1981-10-07 1982-10-06 Heterocyclic compounds and antibacterial and antifungal compositions containing the same as active ingredients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP660982A JPS58124765A (en) 1982-01-19 1982-01-19 Pyrrole derivative, its preparation, and antifungal containing the same as active ingredient

Publications (2)

Publication Number Publication Date
JPS58124765A JPS58124765A (en) 1983-07-25
JPH0144182B2 true JPH0144182B2 (en) 1989-09-26

Family

ID=11643089

Family Applications (1)

Application Number Title Priority Date Filing Date
JP660982A Granted JPS58124765A (en) 1981-10-07 1982-01-19 Pyrrole derivative, its preparation, and antifungal containing the same as active ingredient

Country Status (1)

Country Link
JP (1) JPS58124765A (en)

Also Published As

Publication number Publication date
JPS58124765A (en) 1983-07-25

Similar Documents

Publication Publication Date Title
BG62077B1 (en) NEW 3-PHENYLPYRAZOLE DERIVATIVES AND USE OF THEM
JPS62201849A (en) Benzylamine derivative, its production and use thereof
US4839378A (en) Fluorophthalimides and agricultural and horticultural fungicides containing them
KR880001998B1 (en) Process for the preparing tetrazoles
JPH02157266A (en) N-indanylcarboxylic acid amide derivatives and agricultural and horticultural fungicides containing the same as active ingredients
EP0080051B1 (en) Heterocyclic compounds and antibacterial and antifungal compositions containing the same as active ingredients
JPH0143739B2 (en)
JPH0144182B2 (en)
JPH02200658A (en) N-(substituted) benzylcarboxamide derivative and herbicide
JP2504072B2 (en) Substituted benzoyl derivative and herbicide
US4136189A (en) 2-(5-nitro-furfurylidene)-amino-benzimidoles and fungicidal compositions containing the same
JP3090995B2 (en) 3,4-trans-4-ethyl-3- (substituted phenyl) -1- (3-isopropylphenyl) -2-pyrrolidinone derivative,
JPS63284186A (en) 4-trialkylsilylbenzylamine derivative, production and use thereof
JPS6330900B2 (en)
FR2635776A1 (en) Amide derivatives, process for their manufacture and fungicidal compositions containing them
KR810000679B1 (en) Process for preparing phenylpyrol derivatives
JPH0434547B2 (en)
JPS6353184B2 (en)
JPS6023668B2 (en) Tetrahydrophthalamide derivatives, their production methods and formulations
KR790001458B1 (en) Preparation of 2-iodinebenzanilide
JP2613047B2 (en) Novel 1,2,4-triazole-3-carboxylic acid amide derivative, production method thereof and herbicide containing the same as active ingredient
JPS62195307A (en) Fungicide for agriculture and horticulture
JPH0220636B2 (en)
JPH0434548B2 (en)
JPS6323870A (en) 2-substituted sulfonylpyrimidine derivative